Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to predict dangerous clots and bleeds in heart patients

NCT ID NCT07523880

Recruiting now Knowledge-focused Sponsor: Xueyan Zhao Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study involves over 12,000 Chinese patients with coronary heart disease who take blood thinners. The goal is to find new biological markers that can better predict who is at risk for dangerous blood clots or major bleeding. Researchers will combine genetic, protein, and imaging data with machine learning to create more accurate risk models. This could help doctors choose safer, more personalized treatments for each patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease Hemorrhage hemorrhagic disease thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLEEDING CORONARY ARTERY DISEASE (CAD) THROMBOSIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fuwai Central China Cardiovascular Hospital

    RECRUITING

    Zhengzhou, Henan, China

    Contact

  • Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    RECRUITING

    Beijing, 100037, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • General Hospital of Northern Theater Command of Chinese People's Liberation Army

    RECRUITING

    Shenyang, Liaoning, 110016, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.